Ventricular tachycardia in an ACS patient with acute severe LVF, Immed

Ventricular tachycardia in an ACS patient with acute severe LVF, Immediately after intubation Who has not underwent angioplasty Find some articles abouit and explain me in details

Reading File

Searching the Web

ventricular tachycardia acute coronary syndrome acute heart failure post intubation guideline management

Finding Sources

Searching PubMed

"Ventricular Tachycardia"[MeSH Terms] AND "Acute Coronary Syndrome"

Searching PubMed

"Tracheal Intubation"[MeSH Terms] AND "Cardiac Arrest"[MeSH Terms]

Searching PubMed

"Ventricular Tachycardia"[MeSH Terms] AND "Myocardial Infarction"[MeSH Terms]

Reading File

Finding Sources

Searching PubMed

"Acute Myocardial Infarction"[MeSH Terms] AND "Ventricular Tachycardia"[MeSH Terms] AND revascularization

Searching PubMed

"Tracheal Intubation"[MeSH Terms] AND hypotension AND critically ill

Reading Web Page

https://www.escardio.org/Guidelines/Clinical-Practice-Guidel…

Reading Article

PMID: 29261566

Reading Article

PMID: 41192993

Reading Article

PMID: 29750365

Searching PubMed

"Ventricular Tachycardia"[MeSH Terms] AND "Acute Myocardial Infarction"[MeSH Terms]

Searching the Web

2025 ACC AHA acute coronary syndrome guideline hemodynamic instability life threatening arrhythmias immediate invasive strategy ventricular tachycardia

Finding Sources

Reading Web Page

https://www.ahajournals.org/doi/full/10.1161/CIR.00000000000…

Reading Article

PMID: 37775174

Reading Article

PMID: 40319995

Finding Sources

Clinical interpretation

This is a peri-intubation ventricular tachycardia (VT) occurring in an extremely high-risk situation:

Acute coronary syndrome (ACS), possibly ongoing coronary occlusion
Acute severe LV failure, potentially cardiogenic shock
Intubation and positive-pressure ventilation
No coronary angiography/angioplasty yet

Treat it as VT caused or amplified by acute myocardial ischaemia and peri-intubation haemodynamic collapse until proven otherwise. This requires simultaneous resuscitation and urgent cardiology/catheterisation-laboratory involvement. It is not a situation for “antiarrhythmic treatment only.”

Why VT may occur immediately after intubation

Several processes may act together.

1. Induction and positive-pressure ventilation can abruptly lower cardiac output

A failing LV may be maintaining cardiac output through high sympathetic tone, tachycardia, and preload dependence. Induction drugs can reduce sympathetic tone, venous tone, and blood pressure. Positive-pressure ventilation then increases intrathoracic pressure and reduces venous return.

The result can be:

Lower preload and blood pressure → lower coronary perfusion pressure → more myocardial ischaemia → VT/VF.

The period around intubation is recognised as haemodynamically dangerous. In a multicentre ICU cohort, peri-intubation cardiac arrest occurred in 2.7% of intubations; pre-intubation hypotension and hypoxaemia were strong predictors, and arrest was associated with very high 28-day mortality. See De Jong et al., 2018, PMID 29261566.

2. Hypoxaemia during laryngoscopy or failed preoxygenation

Even a short episode of desaturation increases myocardial oxygen demand and worsens supply-demand mismatch. This is especially arrhythmogenic in severe LV dysfunction and ACS.

A 2025 systematic review and meta-analysis found that peri-intubation interventions, particularly enhanced preoxygenation strategies, reduced hypoxaemia, though evidence for preventing hypotension remained less definitive. See Ren et al., 2025, PMID 41192993.

3. Catecholamine surge

Laryngoscopy, pain, agitation, and insufficient anaesthesia may cause a large sympathetic surge:

Heart rate rises
Afterload rises
Myocardial oxygen consumption rises
Ischaemia worsens
Ventricular ectopy can progress to sustained VT

In a patient with acute pulmonary oedema and ACS, this can be the final trigger.

4. Electrolyte, acid-base, and drug factors

Immediately review for reversible precipitants:

Hypokalaemia or hyperkalaemia
Hypomagnesaemia
Severe acidaemia
Hypoxaemia/hypercapnia
QT-prolonging agents
Excess catecholamines
Loss of arterial pressure after induction
New mechanical complication of MI, such as acute severe MR or ventricular septal rupture

Also rapidly exclude airway-related problems that aggravate shock or hypoxaemia: misplaced tube, severe hypoventilation, tension pneumothorax, or excessive ventilator pressures.

Immediate priorities when VT occurs

Step 1: Decide whether the patient has a pulse and whether VT is causing instability

Pulseless VT/VF

Immediate defibrillation and full cardiac-arrest management.

VT with a pulse but instability

Instability includes hypotension, altered consciousness, ongoing ischaemic chest pain, shock, acute pulmonary oedema, or poor perfusion.
Perform immediate synchronized cardioversion. Do not delay for an antiarrhythmic infusion.

Stable monomorphic VT

Obtain 12-lead ECG if this does not delay care.
Antiarrhythmic therapy can be considered while preparing for cardioversion if deterioration occurs.

In your described patient, severe LV failure after intubation makes the patient functionally “unstable” unless blood pressure and perfusion are clearly preserved. A pulse alone does not make the situation safe.

Step 2: Correct reversible drivers in parallel

Verify oxygenation, ventilation, endotracheal-tube position, and waveform capnography.
Obtain arterial blood gas, potassium, magnesium, ionised calcium, lactate, glucose, and serial ECGs.
Treat significant hypoxaemia and acidaemia.
Correct potassium and magnesium carefully.
Perform focused bedside echocardiography:
- Severe LV impairment?
- RV infarction/failure?
- Acute MR?
- Tamponade?
- Mechanical complication?
- Gross volume status?
Maintain a perfusing arterial pressure with shock-team or critical-care support. Avoid reflex large fluid boluses in pulmonary oedema unless there is convincing evidence of preload-responsive hypovolaemia or RV infarction.

Step 3: Antiarrhythmic choice is secondary to shock control and reperfusion

For ongoing VT in active ischaemia, lidocaine or amiodarone are commonly considered by the resuscitation/cardiology team. In profound LV dysfunction and hypotension, drug selection must account for negative inotropy and vasodilation.

Amiodarone can suppress recurrent VT but IV administration can worsen hypotension in some patients.
Lidocaine has a traditional role in ventricular arrhythmia associated with acute myocardial ischaemia and may be attractive when hypotension limits other drugs.
Procainamide can be effective for stable monomorphic VT but is generally a poor choice in acute severe LV failure, cardiogenic shock, or marked hypotension because it may worsen haemodynamics.
Magnesium is indicated for torsades de pointes or documented/suspected low magnesium, not as routine treatment for all monomorphic VT.
Do not give AV-nodal blocking drugs such as verapamil for an undifferentiated wide-complex tachycardia in structural heart disease.

A practical principle is: electrical treatment for instability, antiarrhythmics for recurrence/suppression, and reperfusion for the underlying ischaemic trigger.

Why the lack of angioplasty matters

If VT is occurring during ACS with acute severe LV failure or cardiogenic shock, the arrhythmia may be a manifestation of ongoing coronary occlusion or severe active ischaemia. Cardioversion can terminate the rhythm, but it does not remove the ischaemic substrate.

Current ACS guidance specifically treats acute severe heart failure, haemodynamic instability, and life-threatening arrhythmias as features warranting an urgent invasive approach. The 2025 ACC/AHA ACS guideline and the 2023 ESC ACS guideline support prompt angiography and revascularisation when appropriate.

So, in this scenario, “no angioplasty yet” should trigger the question:

Is there an untreated culprit coronary lesion that is continuing to produce shock, pulmonary oedema, and ventricular arrhythmia?

If yes, urgent coronary angiography with culprit-vessel PCI when anatomically feasible is often part of definitive treatment, alongside vasopressors/inotropes or mechanical circulatory support when indicated by a multidisciplinary shock team.

Important nuance: evidence showing no long-term reduction in recurrent VT from prior revascularisation in chronic ischaemic cardiomyopathy does not apply to an acute unstable ACS presentation. The VANISH subgroup analysis, PMID 29750365 involved patients with prior MI and recurrent VT, not patients with acute ongoing infarction, acute LV failure, and peri-intubation collapse.

Monomorphic versus polymorphic VT matters

Pattern	Likely implication in ACS	Immediate emphasis
Monomorphic VT	Often scar/re-entry substrate, but acute ischaemia and shock may trigger it	Synchronized cardioversion if unstable; correct triggers; urgent ischaemia assessment
Polymorphic VT with normal QT	Strong concern for acute ischaemia	Defibrillate if unstable/pulseless; treat ischaemia and urgent reperfusion
Torsades de pointes, prolonged QT	Repolarisation abnormality, often drugs/electrolytes	Magnesium, correct K/Mg, stop QT-prolonging drugs, pacing/isoproterenol in selected acquired cases
VT degenerating to VF	Electrical instability with very high mortality risk	Defibrillation, ACLS, urgent correction of ischaemia and shock

Useful articles to read

Peri-intubation cardiovascular collapse
De Jong et al. Cardiac Arrest and Mortality Related to Intubation Procedure in Critically Ill Adult Patients: A Multicenter Cohort Study. Critical Care Medicine. 2018. Observational study. PMID: 29261566.
Focus: incidence, predictors, and outcomes of intubation-related arrest. PubMed record
Preventing peri-intubation hypoxaemia and hypotension
Ren et al. Impact of Interventions on Peri-Intubation Hypoxemia and Hypotension in Critically Ill Patients: Systematic Review and Meta-Analysis. Western Journal of Emergency Medicine. 2025. Systematic review/meta-analysis. PMID: 41192993.
Focus: preoxygenation and haemodynamic prevention strategies. PubMed record and free full text
Practical VT diagnosis and acute management
Whitaker, Wright, and Tedrow. Diagnosis and management of ventricular tachycardia. Clinical Medicine. 2023. Review. PMID: 37775174.
Focus: ECG diagnosis, distinguishing VT from SVT with aberrancy, and acute management concepts. PubMed record
VT in advanced heart failure
Liuba, Sroubek, and Santangeli. Management of ventricular tachycardia in patients with advanced heart failure. Progress in Cardiovascular Diseases. 2025. Review. PMID: 40319995.
Focus: limitations of antiarrhythmics, role of ablation, and haemodynamic risk in severe HF. PubMed record
ACS guideline and invasive treatment
Rao et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025.
Focus: ACS complicated by acute HF, shock, or life-threatening arrhythmias. Guideline

Bottom line

In an ACS patient with severe acute LV failure who develops VT immediately after intubation, think:

Unstable VT? Shock immediately if indicated.
Identify and reverse peri-intubation hypotension, hypoxaemia, acidaemia, electrolytes, and ventilator/airway complications.
Assume active ischaemia is a major driver until excluded.
Activate interventional cardiology urgently because VT plus severe HF/shock is a high-risk ACS phenotype where angiography and likely culprit-vessel PCI can be definitive treatment.

This is a critical-care emergency requiring real-time ACLS, cardiology, interventional, and ICU/shock-team management.

This is a shared conversation. Sign in to Orris to start your own chat.